1. Separation and Analysis of Lactosylceramide, Galabiosylceramide, and Globotriaosylceramide by LC-MS/MS in Urine of Fabry Disease Patients
- Author
-
Vanessa Vaillancourt-Lavigueur, Iskren Menkovic, Christiane Auray-Blais, Amanda Toupin, Tristan Martineau, and Michel Boutin
- Subjects
Adult ,Male ,0301 basic medicine ,Adolescent ,Lactosylceramides ,Globotriaosylceramide ,Urine ,030204 cardiovascular system & hematology ,Tandem mass spectrometry ,Analytical Chemistry ,Young Adult ,03 medical and health sciences ,Lactosylceramide ,chemistry.chemical_compound ,0302 clinical medicine ,Antigens, CD ,Tandem Mass Spectrometry ,Gangliosides ,medicine ,Humans ,Child ,music ,Chromatography, High Pressure Liquid ,Aged ,chemistry.chemical_classification ,Chromatography ,music.instrument ,Chemistry ,Trihexosylceramides ,Infant ,Substrate (chemistry) ,Fatty acid ,Middle Aged ,medicine.disease ,Fabry disease ,030104 developmental biology ,Enzyme ,Biochemistry ,Child, Preschool ,Fabry Disease ,Female - Abstract
Fabry disease is an X-linked lysosomal storage disorder caused by α-galactosidase A (α-GAL A) deficiency. This enzyme contributes to the cellular recycling of glycosphingolipids such as galabiosylceramide (Ga2), globotriaosylceramide (Gb3), and globotriaosylsphingosine (lyso-Gb3) by hydrolyzing the terminal α-galactosyl moiety. Urine and plasma α-GAL A substrates are currently analyzed as biomarkers for the detection, monitoring, and follow-up of Fabry disease patients. The sensitivity of the analysis of Ga2 is decreased by the co-analysis of its structural isomer, lactosylceramide (LacCer), which is not an α-GAL A substrate. A normal-phase ultraperformance liquid chromatography coupled to tandem mass spectrometry (UPLC-MS/MS) methodology, allowing the baseline separation of 12 Ga2 isoforms/analogues from their lactosylceramide counterparts, was developed and validated in urine. The method was multiplexed with the analysis of 12 Gb3 isoforms/analogues having the same fatty acid moieties as those of Ga2 fo...
- Published
- 2017
- Full Text
- View/download PDF